Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nina Becher

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Clinical Medicine|November 14, 2023
Heart Rate Reduction and Outcomes in Heart Failure OutpatientsFelix Memenga, Meike Rybczynski, Christina Magnussen, et al.
Circulation|November 12, 2023
Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA TrialsWilliam F McIntyre, Alexander P Benz, Nina Becher, et al.
Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie|April 3, 2015
[Psychodynamically oriented inpatient psychotherapy of depressive disorders - First findings from a naturalistic, multicenter study]Matthias Franz, Daniel Seidler, Dörte Jenett, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 11, 2024
Incidence, implications, and management of sense-B-noise failure in subcutaneous cardioverter-defibrillator patients: insights from a large multicentre registryJonas Wörmann, Marc Strik, Stjepan Jurisic, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 17, 2024
Occurrence of premature battery depletion in a large multicentre registry of subcutaneous cardioverter-defibrillator patientsJonas Wörmann, Marc Strik, Stjepan Jurisic, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 1, 2025
Effects of anticoagulation in patients with device-detected atrial fibrillation and multiple stroke risk factors: a win ratio analysis of the NOAH-AFNET 6 trialNina Becher, Gina Köllner, Emanuele Bertaglia, et al.
Journal of the American Heart Association|August 27, 2024
Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 TrialHans Christoph Diener, Nina Becher, Susanne Sehner, et al.
The New England Journal of Medicine|August 25, 2023
Anticoagulation with Edoxaban in Patients with Atrial High-Rate EpisodesPaulus Kirchhof, Tobias Toennis, Andreas Goette, et al.
European Heart Journal|November 13, 2023
Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 hNina Becher, Tobias Toennis, Emanuele Bertaglia, et al.
European Heart Journal|September 2, 2024
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trialsRenate B Schnabel, Juan Benezet-Mazuecos, Nina Becher, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Clinical Medicine|November 14, 2023
Heart Rate Reduction and Outcomes in Heart Failure OutpatientsFelix Memenga, Meike Rybczynski, Christina Magnussen, et al.
Circulation|November 12, 2023
Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA TrialsWilliam F McIntyre, Alexander P Benz, Nina Becher, et al.
Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie|April 3, 2015
[Psychodynamically oriented inpatient psychotherapy of depressive disorders - First findings from a naturalistic, multicenter study]Matthias Franz, Daniel Seidler, Dörte Jenett, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 11, 2024
Incidence, implications, and management of sense-B-noise failure in subcutaneous cardioverter-defibrillator patients: insights from a large multicentre registryJonas Wörmann, Marc Strik, Stjepan Jurisic, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|June 17, 2024
Occurrence of premature battery depletion in a large multicentre registry of subcutaneous cardioverter-defibrillator patientsJonas Wörmann, Marc Strik, Stjepan Jurisic, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|September 1, 2025
Effects of anticoagulation in patients with device-detected atrial fibrillation and multiple stroke risk factors: a win ratio analysis of the NOAH-AFNET 6 trialNina Becher, Gina Köllner, Emanuele Bertaglia, et al.
Journal of the American Heart Association|August 27, 2024
Anticoagulation in Patients With Device-Detected Atrial Fibrillation With and Without a Prior Stroke or Transient Ischemic Attack: The NOAH-AFNET 6 TrialHans Christoph Diener, Nina Becher, Susanne Sehner, et al.
The New England Journal of Medicine|August 25, 2023
Anticoagulation with Edoxaban in Patients with Atrial High-Rate EpisodesPaulus Kirchhof, Tobias Toennis, Andreas Goette, et al.
European Heart Journal|November 13, 2023
Anticoagulation with edoxaban in patients with long atrial high-rate episodes ≥24 hNina Becher, Tobias Toennis, Emanuele Bertaglia, et al.
European Heart Journal|September 2, 2024
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trialsRenate B Schnabel, Juan Benezet-Mazuecos, Nina Becher, et al.
Pageof 2